DE69933046D1 - Reinigung von echinocandin cyclopeptiden - Google Patents

Reinigung von echinocandin cyclopeptiden

Info

Publication number
DE69933046D1
DE69933046D1 DE69933046T DE69933046T DE69933046D1 DE 69933046 D1 DE69933046 D1 DE 69933046D1 DE 69933046 T DE69933046 T DE 69933046T DE 69933046 T DE69933046 T DE 69933046T DE 69933046 D1 DE69933046 D1 DE 69933046D1
Authority
DE
Germany
Prior art keywords
acetic acid
fermentation
products
echinocandin
cyclopeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69933046T
Other languages
English (en)
Other versions
DE69933046T2 (de
Inventor
Robert Dobbins
Paul Kroeff
Thomas Vicenzi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of DE69933046D1 publication Critical patent/DE69933046D1/de
Publication of DE69933046T2 publication Critical patent/DE69933046T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69933046T 1998-12-09 1999-12-08 Reinigung von echinocandin cyclopeptiden Expired - Fee Related DE69933046T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11152498P 1998-12-09 1998-12-09
US111524P 1998-12-09
PCT/US1999/029008 WO2000034315A2 (en) 1998-12-09 1999-12-08 Purification of echinocandin cyclopeptide compounds

Publications (2)

Publication Number Publication Date
DE69933046D1 true DE69933046D1 (de) 2006-10-12
DE69933046T2 DE69933046T2 (de) 2007-09-13

Family

ID=22339024

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69933046T Expired - Fee Related DE69933046T2 (de) 1998-12-09 1999-12-08 Reinigung von echinocandin cyclopeptiden

Country Status (17)

Country Link
US (1) US6506726B1 (de)
EP (1) EP1137663B1 (de)
JP (1) JP2003511345A (de)
KR (1) KR20010101151A (de)
CN (1) CN1337968A (de)
AT (1) ATE338059T1 (de)
AU (1) AU766091B2 (de)
BR (1) BR9916101A (de)
CA (1) CA2353930A1 (de)
DE (1) DE69933046T2 (de)
DK (1) DK1137663T3 (de)
ES (1) ES2272096T3 (de)
IL (1) IL143563A0 (de)
PT (1) PT1137663E (de)
RU (1) RU2001118849A (de)
WO (1) WO2000034315A2 (de)
ZA (1) ZA200104621B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743777B1 (en) * 1992-03-19 2004-06-01 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof
DK1155034T3 (da) 1999-03-03 2007-01-08 Lilly Co Eli Dannelse og anionbytning af indre krystallinske echinocandin B-ammoniumsalte
IL145187A0 (en) 1999-03-03 2002-06-30 Lilly Co Eli Echinocandin/carbohydrate complexes
CA2362482A1 (en) 1999-03-03 2000-09-08 Eli Lilly And Company Processes for making pharmaceutical oral ecb formulations and compositions
RU2250763C2 (ru) 1999-03-03 2005-04-27 Эли Лилли Энд Компани Фармацевтические препараты эхинокандина, содержащие мицелообразующие поверхностно-активные вещества
US6991800B2 (en) * 2002-06-13 2006-01-31 Vicuron Pharmaceuticals Inc. Antifungal parenteral products
CN101005859B (zh) * 2004-06-29 2012-08-15 利莱恩斯生命科学有限公司 灭病毒生物液体的制备方法
DE102004060750A1 (de) * 2004-12-15 2006-07-13 Sanofi-Aventis Deutschland Gmbh Verfahren zur Deacylierung von Lipopeptiden
TW200826957A (en) * 2006-10-16 2008-07-01 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Purification processes for echinocandin-type compounds
US9394340B2 (en) 2009-03-24 2016-07-19 Cadila Healthcare Limited Purification process for lipopeptides
CN102219832B (zh) 2010-04-15 2013-08-21 上海天伟生物制药有限公司 一种氮杂环六肽或其盐的纯化方法
CN102336817B (zh) * 2010-07-16 2016-06-15 浙江震元制药有限公司 棘球白素b母核的分离方法
CA2813330A1 (en) * 2010-09-29 2012-04-05 Shanghai Techwell Biopharmaceutical Co., Ltd. Process for purifying cyclolipopeptide compounds or the salts thereof
CA2813335A1 (en) * 2010-09-30 2012-04-05 Shanghai Techwell Biopharmaceutical Co., Ltd. Process for purifying cyclolipopeptide compounds or salts thereof
CN102153616A (zh) * 2010-12-27 2011-08-17 浙江海正药业股份有限公司 一种环己肽类化合物及其盐的分离纯化方法
CN103889221B (zh) * 2011-03-03 2016-08-31 西蔡德制药公司 抗真菌剂及其应用
SI2699327T1 (sl) * 2011-04-20 2015-11-30 Xelia Pharmaceuticals Aps Postopek čiščenja mikafungina
CN102952178B (zh) * 2011-08-24 2016-04-27 华北制药集团新药研究开发有限责任公司 一种高纯度棘白霉素类化合物的制备方法
KR102061486B1 (ko) 2012-03-19 2020-01-03 시다라 세라퓨틱스, 인코포레이티드 에키노칸딘 계열의 화합물에 대한 투여 용법
CN103483427A (zh) * 2012-06-09 2014-01-01 浙江海正药业股份有限公司 一种棘白菌素类化合物的纯化方法
CN103910783B (zh) * 2014-04-23 2016-07-06 华北制药集团新药研究开发有限责任公司 一种高纯度棘白霉素b母核的制备方法
EP3058958B1 (de) 2015-02-23 2018-09-19 Selectchemie AG Anidulafunginzusammensetzung
WO2017120471A1 (en) 2016-01-08 2017-07-13 Cidara Therapeutics, Inc. Methods for preventing and treating pneumocystis infections
CN109154603A (zh) 2016-03-16 2019-01-04 奇达拉治疗公司 用于治疗真菌感染的给药方案
CN106248857A (zh) * 2016-07-15 2016-12-21 广西医科大学 利用薄层层析快速检测植物环肽的方法
WO2019014333A1 (en) 2017-07-12 2019-01-17 Cidara Therapeutics, Inc. COMPOSITIONS AND METHODS FOR THE TREATMENT OF FUNGAL INFECTIONS

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4293482A (en) 1979-12-13 1981-10-06 Eli Lilly And Company A-30912A Nucleus
US4293489A (en) 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912A nucleus
US4304716A (en) 1979-12-13 1981-12-08 Eli Lilly And Company S 31794/F-1 Nucleus
US4320052A (en) 1979-12-13 1982-03-16 Eli Lilly And Company Derivatives of A-30912A nucleus
EP0294990A3 (de) * 1987-06-10 1990-05-09 Eli Lilly And Company Chromatographisches Reinigungsverfahren
US4874843A (en) 1987-12-03 1989-10-17 Eli Lilly And Company Chromatographic purification process
DK173802B1 (da) 1988-09-12 2001-11-05 Merck & Co Inc Præparat til behandling af Pneumocystis carinii infeksioner og anvendelse af et cyclohexapeptid til fremstilling af et lægemiddel mod Pneumocystis carinii infektioner
US5166135A (en) 1988-09-12 1992-11-24 Merck & Company, Inc. Method for the control of pneumocystis carinii
US5310726A (en) 1990-03-19 1994-05-10 Merck & Co., Inc. Lipopeptide compounds
EP0460882B1 (de) 1990-06-07 1996-07-24 Eli Lilly And Company Lipopeptid Deacylase
IE990233A1 (en) 1990-06-18 2000-11-15 Fujisawa Pharmaceutical Co New Polypeptide Compound and a Process for Preparation thereof
US5965525A (en) 1992-03-19 1999-10-12 Eli Lilly And Company Cyclic peptide antifungal agents
TW264477B (de) 1992-03-19 1995-12-01 Lilly Co Eli
US5541160A (en) 1994-04-04 1996-07-30 Merck & Co., Inc. Antifungal and anti-pneumocystis compounds, compositions containing such compounds, and methods of use
US5646111A (en) 1995-04-07 1997-07-08 Eli Lilly And Company Cyclic peptide antifungal Agents
US5629290A (en) 1995-05-26 1997-05-13 Eli Lilly And Company Cyclic peptide antifungal agents
US5652213A (en) 1995-05-26 1997-07-29 Eli Lilly And Company Cyclic peptide antifungal agents
US5618787A (en) 1995-05-26 1997-04-08 Eli Lilly And Company Cyclic peptide antifungal agents
US5786325A (en) 1995-05-26 1998-07-28 Eli Lilly And Company Cyclic peptide antifungal agents and methods of making and using
US5629289A (en) 1995-07-25 1997-05-13 Eli Lilly And Company Cyclic peptide antifungal agents
AU1851797A (en) 1996-02-01 1997-08-22 Eli Lilly And Company Cyclic peptide antifungal agents
US5696084A (en) 1996-08-16 1997-12-09 Abbott Laboratories Amino-lipopetide antifungal agents
WO1999006062A1 (en) 1997-08-04 1999-02-11 Eli Lilly And Company Cyclic peptide antifungal agents
CA2255140A1 (en) 1997-12-23 1999-06-23 Eli Lilly And Company Echinocandin binding domain of 1,3-.beta.-glucan synthase
US6323176B1 (en) 1998-02-25 2001-11-27 Eli Lilly And Company Cyclic peptide antifungal agents
CA2340676A1 (en) 1998-08-20 2000-03-02 Eli Lilly And Company Ring modified cyclic peptide analogs
WO2000012540A1 (en) 1998-08-28 2000-03-09 Eli Lilly And Company Reversible boronate complexes of 1,2-cis-diol cyclic-peptides
AU1517900A (en) 1998-10-28 2000-05-15 Eli Lilly And Company Photochemical process for making 1-deoxy-2-keto derivatives
AU2189500A (en) 1998-12-16 2000-07-03 Eli Lilly And Company Cyclic peptide antifungal agents having a sugar substituent
CA2354056A1 (en) 1998-12-16 2000-06-22 James Andrew Jamison Cyclic peptide antifungal agents
CA2362482A1 (en) 1999-03-03 2000-09-08 Eli Lilly And Company Processes for making pharmaceutical oral ecb formulations and compositions
DK1155034T3 (da) 1999-03-03 2007-01-08 Lilly Co Eli Dannelse og anionbytning af indre krystallinske echinocandin B-ammoniumsalte
IL145187A0 (en) 1999-03-03 2002-06-30 Lilly Co Eli Echinocandin/carbohydrate complexes
RU2250763C2 (ru) 1999-03-03 2005-04-27 Эли Лилли Энд Компани Фармацевтические препараты эхинокандина, содержащие мицелообразующие поверхностно-активные вещества

Also Published As

Publication number Publication date
DE69933046T2 (de) 2007-09-13
ES2272096T3 (es) 2007-04-16
ATE338059T1 (de) 2006-09-15
RU2001118849A (ru) 2003-08-10
EP1137663B1 (de) 2006-08-30
JP2003511345A (ja) 2003-03-25
DK1137663T3 (da) 2007-01-08
PT1137663E (pt) 2006-12-29
AU3113200A (en) 2000-06-26
WO2000034315A3 (en) 2000-12-28
ZA200104621B (en) 2002-06-06
KR20010101151A (ko) 2001-11-14
WO2000034315A8 (en) 2000-10-26
CA2353930A1 (en) 2000-06-15
BR9916101A (pt) 2002-06-04
AU766091B2 (en) 2003-10-09
EP1137663A2 (de) 2001-10-04
US6506726B1 (en) 2003-01-14
CN1337968A (zh) 2002-02-27
WO2000034315A2 (en) 2000-06-15
IL143563A0 (en) 2002-04-21

Similar Documents

Publication Publication Date Title
DE69933046D1 (de) Reinigung von echinocandin cyclopeptiden
JP2563726B2 (ja) 本質的に純粋なヒト副甲状腺ホルモン
MX9707909A (es) Purificacion de anticuerpos.
ATE249244T1 (de) Aktivierte verbindungen und verfahren zur herstellung und reiningung
ATE200293T1 (de) Verfahren zur chromatographischen reinigung und trennung von nucleinsäuregemischen
ES2139794T3 (es) Purificacion de inhibidor de proteinasa alfa-1 usando nuevas condiciones de separacion cromatografica.
ATE282044T1 (de) Chromatographische reinigung von chlorinierter sukrose
FI93228B (fi) Menetelmä vankomysiinityyppisen glykopeptidiantibiootin talteenottamiseksi
Hearn et al. Application of Reversed Phase High Performance Liquid Chromatography in Solid Phase Peptide Synthesis: High Pressure Liquid Chromatography of Amino Acids Peptides and Proteins XIII. Part XII Ref. 2
WO2004026891A3 (en) Protein purification
Bishop et al. High-performance liquid chromatography of amino acids, peptides and proteins: XXI. The application of preparative reversed-phase high-performance liquid chromatography for the purification of a synthetic underivatised peptide
ATE268338T1 (de) Antibiotische cryptdin-peptide und verfahren zur ihrer verwendung
JPH03118393A (ja) ペプチド又はプソイドペプチド構造の低分子量化合物の精製方法
CA2306447A1 (en) Purification of molecules
WO1999009004A3 (en) Process for preparing and/or purifying amido acid phenyl ester sulfonates
AU4263493A (en) Method for purifying an aqueous solution of raw albumin
HU9501479D0 (en) Displacement chromatography process and purified hemoglobin product
Joubert et al. Purification, some properties and the primary structures of three reduced and S-carboxymethylated toxins (CM-5, CM-6 and CM-10a) from Naje haje haje (Egyptian cobra) venom
DE69408631T2 (de) Verfahren zur reinigung eines hydrophoben polypeptides
Bishop et al. The Preparative Separation of Synthetic Peptides on Reversed-Phase Silica Packed in Radially Compressed Flexible-Walled Columns.+
Dillon et al. HETEROGENEITY OF INSULIN: I. ISOLATION OF A CHROMATOGRAPHICALLY PURIFIED, HIGH-POTENCY INSULIN AND SOME OF ITS PROPERTIES
BENSON et al. Isolation and structure elucidation of bovine pineal arginine vasopressin: arginine vasotocin not identified
BR9813522A (pt) Processos para separar e purificar apm e metil éster de n-[n-(3,3-dimetilbutil)-l-alfa-aspartil]-l-fenilalanina e para a produção do derivado de apm, apm ou derivado de apm, e, adoçante
SU767121A1 (ru) Способ выделени и очистки трипсина и химотрипсина
Pedroso et al. Reversed-phase high-performance liquid chromatography of protected peptide segments

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee